1. Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs
   Fangrong Zhang et al, 2016, AAPS PharmSciTech CrossRef
2. Tranilast induces MiR-200c expression through blockade of RelA/p65 activity in leiomyoma smooth muscle cells
   Tsai-Der Chuang et al, 2020, Fertility and Sterility CrossRef
3. Synthesis, Bioactivity Evaluation, and Molecular Docking Study of Tranilast Analogs as Anticancer Agents
   Phuong-Thuy T. Phan et al, 2024, Letters in Organic Chemistry CrossRef
4. Challenges in the Discovery of Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors
   Ute F. Röhrig et al, 2015, Journal of Medicinal Chemistry CrossRef
5. Anti-cancer effects of Tranilast: An update
   Soha Osman et al, 2021, Biomedicine & Pharmacotherapy CrossRef
6. Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation
   Kodappully S. Siveen et al, 2019, Scientific Reports CrossRef
7. Repurposing of Tranilast for Potential Neuropathic Pain Treatment by Inhibition of Sepiapterin Reductase in the BH4 Pathway
   Benjamin J. R. Moore et al, 2019, ACS Omega CrossRef
8. Tranilast Inhibits Genes Functionally Involved in Cell Proliferation, Fibrosis, and Epigenetic Regulation and Epigenetically Induces miR-29c Expression in Leiomyoma Cells
   Tsai-Der Chuang et al, 2017, Reproductive Sciences CrossRef